In 2020, Liu and coworkers reported the use of NAD(P)H:quinone oxidoreductase 1 (NQO1)-responsive photosensitizer-conjugated polymeric vesicles for tumor imaging and therapy [59]. This evidence concerns the gene NQO1 and neoplasm.